Zila Names David R. Bethune Executive Chairman; Adds J. Steven Garrett to Board of Directors
August 16 2007 - 4:03PM
PR Newswire (US)
PHOENIX, Aug. 16 /PRNewswire-FirstCall/ -- Zila, Inc. (NASDAQ:ZILA)
today announced that its board of directors has named David R.
Bethune as executive chairman. Bethune has been a member of the
board since 2005 and was appointed chairman on May 21, 2007. The
board also elected J. Steven Garrett, MS, DDS, FACD, as a director.
Garrett, 62, fills the vacancy created by the departure of Hazel L.
Myer, who recently resigned from the board. "I am very pleased to
welcome Steve to our board," said David Bethune. "He brings
extensive expertise in the clinical study of oncology products as
well as relevant experience gained as a professor of periodontics
and in private practice as a dentist/periodontist. "I also would
like to thank Rusty Myer for her service to Zila. We are grateful
for all of her advice and guidance and wish her the best in all of
her future endeavors." Dr. Garrett has more than 30 years of
experience in broad healthcare areas. He served as senior vice
president clinical research for QLT USA, Inc., where, among other
responsibilities, he managed all of that company's clinical trials,
interfaced with the FDA and coordinated the clinical portion of
regulatory submissions. Previously, Dr. Garrett served as chairman
of the department of periodontics at Loma Linda University as well
as director of the advanced education program in periodontics and
implant dentistry. Earlier, he owned and operated a private
dentistry practice, specializing in periodontics and implant
dentistry. About Zila, Inc. Zila, Inc., headquartered in Phoenix,
is an oral cancer screening company focused on the prevention and
treatment of oral disease. Zila is dedicated to establishing
ViziLite(R) Plus as the new standard of care for the early
detection of oral abnormalities that could lead to cancer, with an
initial focus on the dental market through Pro-Dentec(R), a leading
designer, manufacturer and marketer of Soft Tissue Management
(STM(R)) products. Sold exclusively and directly to dental
professionals, Pro-Dentec's core products include the Rota-dent(R)
Professional Powered Brush, the Pro- Select3(R) Piezo-Ultrasonic
Scaler System and a suite of pharmaceutical STM(R) products for
both in-office and home-care use. For more information about Zila,
visit http://www.zila.com/. DATASOURCE: Zila, Inc. CONTACT: Robert
Jaffe of PondelWilkinson Inc., +1-310-279-5969, for Zila, Inc. Web
site: http://www.zila.com/
Copyright
Zila (NASDAQ:ZILA)
Historical Stock Chart
From May 2024 to Jun 2024
Zila (NASDAQ:ZILA)
Historical Stock Chart
From Jun 2023 to Jun 2024